Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Sequential Analysis
84%
Randomized Clinical Trial
84%
Cardiovascular Disease
82%
Cardiovascular System
78%
Systematic Review with Meta-Analysis
77%
Systematic Review
72%
Blood Pressure
50%
Meta-Analysis
48%
Congestive Heart Failure
44%
Cohort Analysis
41%
Cardiovascular Risk
39%
Placebo
37%
Adverse Event
36%
All Cause Mortality
31%
Biological Marker
31%
Quality of Life
31%
Randomized Controlled Trial
24%
Atrial Fibrillation
23%
Systolic Blood Pressure
22%
Patient with Type 2 Diabetes
22%
Clinical Trial
19%
Diabetes
18%
Brain Natriuretic Peptide
17%
Apoplexy
17%
Amino Terminal Sequence
17%
Birth Weight
16%
Aortic Stenosis
14%
Primary Health Care
14%
Physical Activity
14%
Prevalence
14%
Blood Pressure Measurement
14%
Hazard Ratio
14%
Drug Therapy
13%
Postoperative Pain
13%
Insulin Sensitivity
13%
Kidney Function
13%
Coronary Artery Disease
12%
Clinician
12%
Opiate
12%
Obesity
11%
Patient with Hypertension
11%
Body Weight
11%
Body Mass Index
11%
Osteoporosis
11%
Antidepressant
11%
Pulse Wave Velocity
11%
Paracetamol
11%
Sepsis
11%
Intima-Media Thickness
11%
Proton-Pump Inhibitor
11%
Cell Function
11%
Arterial Stiffness
11%
Intensive Care Unit
10%
Disease
10%
Type 2 Diabetes
10%
Ibuprofen
10%
Proportional Hazards Model
10%
Urokinase Receptor
10%
Volunteer
10%
Left Ventricular Hypertrophy
10%
Myocardial Infarction
10%
Cardiovascular Mortality
10%
C Reactive Protein
10%
Risk Stratification
10%
Sildenafil
9%
Gastrointestinal Bleeding
9%
Total Knee Arthroplasty
9%
Hamilton Rating Scale for Depression
9%
Delirium
9%
Dexamethasone
9%
Chronic Obstructive Pulmonary Disease
9%
Low Carbohydrate Diet
9%
Dexmedetomidine
9%
Prospective Study
9%
Osteogenesis Imperfecta
9%
Stress Ulcer
9%
Neonatal Sepsis
9%
Fetus Growth
9%
Out of Hospital Cardiac Arrest
9%
Hypothermia
9%
Calcitonin Gene Related Peptide
9%
Migraine
9%
Monoclonal Antibody
9%
Absorptiometry
9%
Electrocardiogram
9%
Health Care Cost
8%
Low Birth Weight
8%
Arm
8%
Ischemic Heart Disease
8%
Echocardiography
8%
Major Depressive Episode
8%
Personalized Medicine
8%
Brain Injury
7%
Diastolic Blood Pressure
7%
Health System
7%
Vascular Disease
7%
Shock (Circulatory)
7%
Subgroup Analysis
7%
Gestational Age
6%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Clinical Trial
68%
Cardiovascular Disease
67%
Congestive Heart Failure
62%
All Cause Mortality
62%
Adverse Event
60%
Cardiovascular Risk
55%
Non Insulin Dependent Diabetes Mellitus
52%
Cohort Study
52%
Placebo
43%
Biological Marker
31%
Heart Infarction
29%
Atrial Fibrillation
27%
Brain Natriuretic Peptide
25%
Cardiovascular Mortality
21%
Intervention Trial
19%
Cerebrovascular Accident
19%
Coronary Artery Disease
17%
Opiate
17%
Clinical Trial
17%
Beta Adrenergic Receptor Blocking Agent
16%
Sepsis
16%
Randomized Controlled Trial
16%
Disease
15%
Ischemic Heart Disease
15%
Delirium
14%
Aortic Stenosis
14%
Bisphosphonic Acid Derivative
12%
Antihypertensive Agent
11%
C Reactive Protein
11%
Obesity
11%
Antibiotics
11%
Proton Pump Inhibitor
11%
Normal Human
11%
Replacement Therapy
10%
Chronic Kidney Failure
10%
Inflammation
10%
Heart Atrium Flutter
9%
Dexmedetomidine
9%
Newborn Sepsis
9%
Tramadol
9%
Gastrointestinal Hemorrhage
9%
Cannabinoid
9%
Migraine
9%
Monoclonal Antibody
9%
Calcitonin Gene Related Peptide
9%
Anticoagulant Agent
9%
Comorbidity
9%
Acute Heart Infarction
9%
Low Birth Weight
8%
Heart Arrhythmia
8%
Eating Disorder
8%
Heart Left Ventricle Hypertrophy
8%
Risk Evaluation
7%
Urokinase Receptor
7%
Remission
7%
Hip Fracture
7%
Triacylglycerol
7%
Hypotension
6%
Dexamethasone
6%
Valsartan/Sacubitril
6%
Prevalence
6%
Chronic Pain
6%
Enkephalinase Inhibitor
6%
Anorexia Nervosa
6%
Troponin T
5%
Cancer Pain
5%
Malignant Neoplasm
5%
Glucocorticoid
5%
Paracetamol
5%
Postoperative Pain
5%
Diabetes Mellitus
5%
Heart Muscle Ischemia
5%
Enteritis
5%
Peptoclostridium difficile
5%
Antidiabetic Agent
5%
Natriuretic Factor
5%
Interleukin 6
5%
Simvastatin
5%
Ezetimibe
5%
Coronary Risk
5%
Prospective Study
5%
Fragility Fracture
5%
Statin (Protein)
5%
Framingham Risk Score
5%
Nursing and Health Professions
Blood Pressure
66%
Non Insulin Dependent Diabetes Mellitus
39%
Cardiovascular Disease
35%
Systematic Review
25%
Systematic Review with Meta-Analysis
21%
Systolic Blood Pressure
19%
Cardiovascular Risk
19%
Adverse Event
19%
Sequential Analysis
17%
Confidence Interval
16%
Practice Guideline
15%
Meta Analysis
15%
Delirium
14%
Pressure Control
12%
Quality of Life
12%
Hospital
11%
Drug Therapy
11%
C Reactive Protein
10%
Telehealth
10%
Body Weight
10%
Primary Medical Care
9%
Patient with Hypertension
9%
Inflammation
9%
Dexmedetomidine
9%
Brain Natriuretic Peptide
9%
Biological Marker
9%
Antidepressant
8%
Body Mass
8%
All Cause Mortality
8%
Placebo
8%
Major Depression
8%
Opiate
7%
Oxygenation
7%
Blood Pressure Measurement
7%
Congestive Heart Failure
7%
near Infrared Spectroscopy
6%
Sepsis
6%
Disease
6%
Dual Energy X Ray Absorptiometry
6%
Cohort Analysis
5%
Volunteer
5%
Pulse Wave
5%
Brain Injury
5%
Body Composition
5%
Age Groups
5%
Cost Effectiveness Analysis
5%
Predictive Value
5%
Correlation Coefficient
5%
Coronary Artery Disease
5%
Triacylglycerol
5%